Lipella Pharmaceuticals Inc.
LIPO
$0.31
$0.0311.80%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.86M | 2.78M | 4.23M | 2.18M | 1.35M |
| Total Receivables | -- | 42.00K | 85.60K | 84.70K | 31.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 223.50K | 613.40K | 512.70K | 347.70K | 695.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 0.00 | 0.00 | -- | -- |
| Total Current Assets | 2.08M | 3.44M | 4.82M | 2.62M | 2.08M |
|
|
|||||
| Total Current Assets | 2.08M | 3.44M | 4.82M | 2.62M | 2.08M |
| Net Property, Plant & Equipment | 270.50K | 283.00K | 32.70K | 56.60K | 80.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.35M | 3.72M | 4.86M | 2.67M | 2.16M |
|
|
|||||
| Total Accounts Payable | 462.90K | 608.10K | 392.10K | 388.20K | 459.50K |
| Total Accrued Expenses | 135.20K | 95.90K | 360.70K | 318.60K | 170.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 44.30K | 42.90K | 24.00K | 47.60K | 70.80K |
| Total Finance Division Other Current Liabilities | -- | -- | 0.00 | -- | -- |
| Total Other Current Liabilities | -- | -- | 0.00 | -- | -- |
| Total Current Liabilities | 642.40K | 746.90K | 776.80K | 754.40K | 701.20K |
|
|
|||||
| Total Current Liabilities | 642.40K | 746.90K | 776.80K | 754.40K | 701.20K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 219.80K | 231.60K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 0.00 | -- | 0.00 |
| Total Liabilities | 862.20K | 978.50K | 776.80K | 754.40K | 701.20K |
|
|
|||||
| Common Stock & APIC | 20.72M | 20.72M | 20.73M | 17.26M | 15.36M |
| Retained Earnings | -19.23M | -17.97M | -16.65M | -15.34M | -13.90M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.49M | 2.74M | 4.08M | 1.92M | 1.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 100.00 | 0.00 | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 100.00 | 0.00 | -- |
|
|
|||||
| Total Common Equity | 1.49M | 2.74M | 4.08M | 1.92M | 1.46M |
| Total Preferred Equity | 0.00 | 0.00 | 100.00 | 0.00 | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.49M | 2.74M | 4.08M | 1.92M | 1.46M |
|
|
|||||